SCHEMBL29515017

SCHEMBL29515017

Cc1c(-c2nc(Cl)ncc2F)sc2c(C(C)C)cncc12

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCND1 P24385 7/20 0.51
CDK6 Q00534 4/20 0.51
CDK4 P11802 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24323632 1.00 CCND1 (0.51) CCND1CDK6CDK4
SCHEMBL25695270 0.78 CCND1 (0.41) CCND1CDK6CDK4
SCHEMBL24322358 0.73 CCND1 (0.57) CCND1CDK6CDK4
SCHEMBL24322930 0.72 CCND1 (0.46) CCND1CDK6CDK4
SCHEMBL29514922 0.69 CCND1 (0.42) CCND1CDK6CDK4
SCHEMBL24322278 0.69 CCND1 (0.42) CCND1CDK6CDK4
SCHEMBL29514933 0.69 CCND1 (0.41) CCND1CDK6CDK4
SCHEMBL24322202 0.69 CCND1 (0.41) CCND1CDK6CDK4
SCHEMBL30541555 0.68 CCND1 (0.54) CCND1CDK6CDK4
SCHEMBL24322989 0.68 CCND1 (0.54) CCND1CDK6CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116583283-A CDK inhibitors and their use as pharmaceuticals 普莱鲁德疗法有限公司 2023-08-11 CN disclosed
EP-4214213-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Prelude Therapeutics, Incorporated (US) 2023-07-26 EP disclosed
WO-2022061273-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2022-03-24 WO disclosed